Murai H - Search Results

1

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.

Murai H, Uzawa A, Suzuki Y, Imai T, Shiraishi H, Suzuki H, Okumura M, O'Brien F, Wang JJ, Fujita KP, Utsugisawa K; REGAIN Study Group. Murai H, et al. J Neurol Sci. 2019 Dec 15;407:116419. doi: 10.1016/j.jns.2019.08.004. Epub 2019 Aug 3. J Neurol Sci. 2019. PMID: 31698177 Free article.

2

Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.

Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J. Ochi H, et al. Among authors: murai h. J Neurol Sci. 2004 Jul 15;222(1-2):65-73. doi: 10.1016/j.jns.2004.04.012. J Neurol Sci. 2004. PMID: 15240198 Clinical Trial.

3

High frequency of allergic conjunctivitis in myasthenia gravis without thymoma.

Murai H, Osoegawa M, Ochi H, Kira J. Murai H, et al. J Neurol Sci. 2004 Oct 15;225(1-2):27-31. doi: 10.1016/j.jns.2004.06.018. J Neurol Sci. 2004. PMID: 15465082

4

Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.

Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J. Mei FJ, et al. Among authors: murai h. J Neurol Sci. 2006 Jul 15;246(1-2):71-7. doi: 10.1016/j.jns.2006.02.008. Epub 2006 Mar 6. J Neurol Sci. 2006. PMID: 16581087

5

Infantile onset myasthenia gravis with MuSK antibodies.

Murai H, Noda T, Himeno E, Kawano Y, Ohyagi Y, Shiraishi H, Motomura M, Kira J. Murai H, et al. Neurology. 2006 Jul 11;67(1):174. doi: 10.1212/01.wnl.0000223835.51268.12. Neurology. 2006. PMID: 16832105 No abstract available.

6

Long-term effects of infrasternal mediastinoscopic thymectomy in myasthenia gravis.

Murai H, Uchiyama A, Mei FJ, Kojima M, Kira J. Murai H, et al. J Neurol Sci. 2009 Dec 15;287(1-2):185-7. doi: 10.1016/j.jns.2009.08.002. Epub 2009 Sep 2. J Neurol Sci. 2009. PMID: 19726063

7

Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey.

Murai H, Yamashita N, Watanabe M, Nomura Y, Motomura M, Yoshikawa H, Nakamura Y, Kawaguchi N, Onodera H, Araga S, Isobe N, Nagai M, Kira J. Murai H, et al. J Neurol Sci. 2011 Jun 15;305(1-2):97-102. doi: 10.1016/j.jns.2011.03.004. Epub 2011 Mar 26. J Neurol Sci. 2011. PMID: 21440910 Free article.

8

Interleukin 2 receptor α chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern Japanese.

Ainiding G, Kawano Y, Sato S, Isobe N, Matsushita T, Yoshimura S, Yonekawa T, Yamasaki R, Murai H, Kira J; South Japan Multiple Sclerosis Genetics Consortium. Ainiding G, et al. Among authors: murai h. J Neurol Sci. 2014 Feb 15;337(1-2):147-50. doi: 10.1016/j.jns.2013.11.037. Epub 2013 Dec 4. J Neurol Sci. 2014. PMID: 24332945

9

Is surgical intervention safe and effective in the treatment of myasthenic blepharoptosis? A multicenter survey in Japan.

Shimizu Y, Suzuki S, Utsugisawa K, Imai T, Murai H, Nagane Y, Tsuda E, Nagasao T, Ogata H, Yazawa M, Suzuki N, Kishi K. Shimizu Y, et al. Among authors: murai h. Eur Neurol. 2014;71(5-6):259-61. doi: 10.1159/000356793. Epub 2014 Feb 5. Eur Neurol. 2014. PMID: 24503883 Free article. No abstract available.

10

Health-related quality-of-life and treatment targets in myasthenia gravis.

Utsugisawa K, Suzuki S, Nagane Y, Masuda M, Murai H, Imai T, Tsuda E, Konno S, Nakane S, Suzuki Y, Fujihara K, Suzuki N. Utsugisawa K, et al. Among authors: murai h. Muscle Nerve. 2014 Oct;50(4):493-500. doi: 10.1002/mus.24213. Epub 2014 Aug 30. Muscle Nerve. 2014. PMID: 24536040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

535 results

Search Page